Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial.

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

Crowley, MJ; McGuire, DK; Alexopoulos, A-S; Jensen, TJ; Rasmussen, S; Saevereid, HA; Verma, S; Buse, JB

Published Date

September 2020

Published In

Diabetes Care

Volume / Issue

43 / 9

Start / End Page

e108 - e110

PubMed ID

32647053

Pubmed Central ID

PMC7440910

Electronic International Standard Serial Number (EISSN)

1935-5548

Digital Object Identifier (DOI)

10.2337/dc20-0437

Language

eng

Conference Location

United States